Trial Profile
A pharmacokinetic and pharmacodynamic phase I study of CHS-1701 in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2015
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Pharmacodynamics; Pharmacokinetics
- 23 Jan 2015 New trial record
- 15 Dec 2014 Primary endpoint has been met, according to Coherus BioSciences SEC filing report 10-Q 2014.